TREATMENT OUTCOMES AND FACTORS RELATED TO FAILURE WHEN SWITCHING FROM COLLOID TO CRYSTALLOID SOLUTIONS IN CHILDREN WITH DENGUE SHOCK SYNDROME AT SOC TRANG OBSTETRICS AND PEDIATRICS HOSPITAL

Hữu Đức Âu, Quang Nghĩa Bùi, Thị Kim Yến Huỳnh, Quốc Trung Lý, Lượng Trần, Thị Kiều Linh Trần

Main Article Content

Abstract

Background: Switching from colloid to crystalloid solutions is a pivotal decision in pediatric Dengue shock syndrome (DSS) management, yet predictors of failure are unclear. Objectives: To evaluate treatment outcomes and investigate factors related to failure when switching from CPT to crystalloid. Methods: A prospective study on 76 children with DSS at Soc Trang Obstetrics and Pediatrics Hospital from May 2024 – to July 2025. Transition failure was defined as hemodynamic instability or a ≥10% hematocrit increase within 2 hours of switching from colloid to crystalloid solutions cessation. Multiple logistic regression was used. Results: Survival rate was 100%; respiratory failure occurred in 74.3%. The transition failure rate was 36.8%. Four independent predictors for failure of switching from colloid to crystalloid solutions were identified: lactate ≥2 mmol/L at transition (OR=43.8), albumin <25 g/L at transition (OR=32.4), a ≥1.5-fold creatinine increase at transition (OR=13.1), and hematocrit ≥45% at shock onset (OR=5.8). The model showed good predictive value (AUC=0.877). Conclusion: Despite high survival, transition failure remains a challenge. Assessing the four factors (lactate, albumin, creatinine, Hct) is crucial for safely de-escalating fluid therapy.

Article Details

References

1. Bộ Y tế (2023), Hướng dẫn chẩn đoán và điều trị Sốt xuất huyết Dengue (Ban hành kèm theo Quyết định số 2760/QĐ-BYT ngày 04 tháng 7 năm 2023), Hà Nội.
2. Lý Tố Khanh, Nguyễn Thanh Hùng, Bùi Quốc Thắng, (2009), “Các yếu tố liên quan đến tái sốc trong sốc sốt xuất huyết Dengue tại Bệnh viện Nhi đồng 1 năm 2007-2008”, Y Học TP. Hồ Chí Minh, 13(1), tr. 200-206.
3. Armenda S., Rusmawatiningtyas D., Makrufardi F., et al. (2021), “Factors associated with clinical outcomes of pediatric dengue shock syndrome admitted to pediatric intensive care unit: A retrospective cohort study”, Annals of Medicine and Surgery, 66, pp. 102472.
4. Celeste G.B., Neal J.T., Nadir Y. (2021), “Timing and Clinical Significance of Fluid Overload in Pediatric Acute Respiratory Distress Syndrome”, Pediatric Critical Care Medicine, 22(9), pp. 795-805.
5. Garcia-Alvarez M., Marik P., & Bellomo R. (2014), “Sepsis-associated hyperlactatemia”, Critical Care, 18(5), pp. 503.
6. Johnson D.J., Bandari B., Bachina P. (2024), “A study of morbidity and mortality markers in children diagnosed with severe dengue illness at a quaternary paediatric intensive care unit”, International Journal of Contemporary Pediatrics, 11(6), pp. 804-811.
7. Luan V.T., Tien V.T.H., Phuong N.T.M., et al. (2025), “Associations of resuscitation fluid load, colloid-to-crystalloid infusion ratio and clinical outcomes in children with dengue shock syndrome”, PLOS Neglected Tropical Diseases, 19(1), pp. e0012786.
8. Moallemi S., Lloyd A. R., Rodrigo C. (2023), “Early biomarkers for prediction of severe manifestations of dengue fever: a systematic review and a meta-analysis”, Scientific Reports, 13(1), pp. 17485.
9. Mohan M., Batra P. (2025), “Unravelling the Enigma of Albumin in Dengue”, Indian Pediatrics, 62(2), pp. 96-97.
10. Preeprem N., Phumeetham S. (2022), “Paediatric dengue shock syndrome and acute respiratory failure: a single-centre retrospective study”, BMJ Paediatrics Open, 6(1), pp. e001578.